Clozapine and visuospatial processing in treatment-resistant schizophrenia

Cognitive Neuropsychiatry

Volumn 18, Issue 6, 2013, Pages 615-630

  Bourque, Josiane ^a,b   Lakis, Nadia ^a,b   Champagne, Julie ^a,b   Stip, Emmanuel ^b   Lalonde, Pierre ^b   Lipp, Olivier ^b   Mendrek, Adrianna ^a,b  

^a BISHOP'S UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Clozapine; Functional magnetic resonance imaging; Schizophrenia; Treatment resistance; Visuospatial processing.

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPTH PERCEPTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; TEMPORAL CORTEX;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; COGNITION; COGNITION DISORDERS; DIBENZOTHIAZEPINES; DRUG RESISTANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISPERIDONE; SCHIZOPHRENIA; SPACE PERCEPTION; YOUNG ADULT;

EID: 84887817726     PISSN: 13546805     EISSN: 14640619     Source Type: Journal    
DOI: 10.1080/13546805.2012.760917     Document Type: Article

References (43)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. (4th ed.). Washington, DC: Author.
2. American Psychiatric Association. 2004. Practice guideline for the treatment of patients with schizophrenia. (2nd ed.). Washington, DC: Author.
3. Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B.,., Lieberman, J. A. (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 159, 1018-1028. doi: 10.1176/appi.ajp.159.6.1018 (Pubitemid 34586949)
4. Bonner-Jackson, A., Grossman, L. S., Harrow, M., &, Rosen, C. (2010). Neurocognition in schizophrenia: A 20-year multi-follow-up of the course of processing speed and stored knowledge. Comprehensive Psychiatry, 51, 471-479. doi: 10.1016/j.comppsych.2010.02.005
5. Braw, Y., Bloch, Y., Mendelovich, S., Ratzoni, G., Gal, G., Harari, H.,., Levkovitz, Y. (2008). Cognition in young schizophrenia outpatients: Comparison of first-episode with multiepisode patients. Schizophrenia Bulletin, 34, 544-554. doi: 10.1093/schbul/sbm115
6. Census. 2001. The National Occupational Classification and the Career Handbook. Retrieved from http://www5.hrsdc.gc.ca/noc/English/CH/2001/ IntroductionNOCandCH.aspx
7. Citrome, L., Bilder, R. M., &, Volavka, J. (2002). Managing treatment-resistant schizophrenia: Evidence from randomized clinical trials. Journal of Psychiatric Practice, 8, 205-215. doi: 10.1097/00131746-200207000- 00004
8. Conley, R. R., &, Buchanan, R. W. (1997). Evaluation of treatment-resistant schizophrenia. Schizophrenia Bulletin, 23, 663-674. doi: 10.1093/schbul/23.4.663 (Pubitemid 27485974)
9. Elie, D., Poirier, M., Chianetta, J., Durand, M., Gregoire, C., &, Grignon, S. (2010). Cognitive effects of antipsychotic dosage and polypharmacy: A study with the BACS in patients with schizophrenia and schizoaffective disorder. Journal of Psychopharmacology, 24, 1037-1044. doi: 10.1177/0269881108100777
10. Friston, K. J. (1995). Commentary and opinion: II. Statistical parametric mapping: Ontology and current issues. Journal of Cerebral Blood Flow and Metabolism, 15, 361-370. doi: 10.1038/jcbfm.1995.45
11. Gogos, A., Gavrilescu, M., Davison, S., Searle, K., Adams, J., Rossell, S. L.,., Egan, G. F. (2010). Greater superior than inferior parietal lobule activation with increasing rotation angle during mental rotation: An fMRI study. Neuropsychologia, 48, 529-535. doi: 10.1016/j.neuropsychologia.2009.10.013
12. Harrison, J., Janlov, M., &, Wheeler, A. J. (2010). Patterns of clozapine prescribing in a mental health service in New Zealand. Pharmacy World and Science, 32, 503-511. doi: 10.1007/s11096-010-9398-5
13. Hori, H., Noguchi, H., Hashimoto, R., Nakabayashi, T., Omori, M., Takahashi, S.,., Kunugi, H. (2006). Antipsychotic medication and cognitive function in schizophrenia. Schizophrenia Research, 86, 138-146. doi: 10.1016/j.schres.2006.05.004 (Pubitemid 44234045)
14. Hugdahl, K., Thomsen, T., &, Ersland, L. (2006). Sex differences in visuo-spatial processing: An fMRI study of mental rotation. Neuropsychologia, 44, 1575-1583. doi: 10.1016/j.neuropsychologia.2006.01.026 (Pubitemid 43849860)
15. Jimenez, J. A., Mancini-Marie, A., Lakis, N., Rinaldi, M., &, Mendrek, A. (2010). Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia. Schizophrenia Research, 122, 53-62. doi: 10.1016/j.schres.2010.03.011
16. Kalkstein, S., Hurford, I., &, Gur, R. C. (2010). Neurocognition in schizophrenia. Current Topics in Behavioral Neurosciences, 4, 373-390.
17. Kane, J., Honigfeld, G., Singer, J., &, Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796. doi: 10.1001/archpsyc.1988.01800330013001
18. Kane, J. M., &, Correll, C. U. (2010). Past and present progress in the pharmacologic treatment of schizophrenia. Journal of Clinical Psychiatry, 71, 1115-1124. doi: 10.4088/JCP.10r06264yel
19. Kay, S. R., Fiszbein, A., &, Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276. doi: 10.1093/schbul/13.2.261 (Pubitemid 18039085)
20. Kontis, D., Theochari, E., Kleisas, S., Kalogerakou, S., Andreopoulou, A., Psaras, R.,., Tsaltas, E. (2010). Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 34, 1333-1341. doi: 10.1016/j.pnpbp.2010.07.029
21. Kosslyn, S. M., Thompson, W. L., Wraga, M., &, Alpert, N. M. (2001). Imagining rotation by endogenous versus exogenous forces: Distinct neural mechanisms. Neuroreport, 12, 2519-2525. doi: 10.1097/00001756-200108080-00046 (Pubitemid 32682214)
22. Kucian, K., von Aster, M., Loenneker, T., Dietrich, T., Mast, F. W., &, Martin, E. (2007). Brain activation during mental rotation in school children and adults. Journal of Neural Transmission, 114, 675-686. doi: 10.1007/s00702-006-0604-5 (Pubitemid 46664047)
23. Lewis, S. W., Barnes, T. R., Davies, L., Murray, R. M., Dunn, G., Hayhurst, K. P.,., Jones, P. B. (2006). Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia Bulletin, 32, 715-723. doi: 10.1093/schbul/sbj067 (Pubitemid 44412859)
24. Liddle, P. F. (1987). The symptoms of chronic schizophrenia: A re-examination of the positive-negative dichotomy. British Journal of Psychiatry, 151, 145-151. doi: 10.1192/bjp.151.2.145 (Pubitemid 17102086)
25. McEvoy, J. P., Lieberman, J. A., Stroup, T. S., Davis, S. M., Meltzer, H. Y., Rosenheck, R. A.,., CATIE Investigators. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163, 600-610. doi: 10.1176/appi.ajp.163.4.600 (Pubitemid 44464569)
26. McGurk, S. R. (1999). The effects of clozapine on cognitive functioning in schizophrenia. Journal of Clinical Psychiatry, 60 (Suppl. 12), 24-29. (Pubitemid 29283179)
27. Meltzer, H. Y. (1997). Treatment-resistant schizophrenia-the role of clozapine. Current Medical Research and Opinion, 14, 1-20. doi: 10.1185/03007999709113338 (Pubitemid 28080714)
28. Meltzer, H. Y., Alphs, L., Green, A. I., Altamura, A. C., Anand, R., Bertoldi, A.,., International Suicide Prevention Trial Study Group. (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry, 60, 82-91. doi: 10.1001/archpsyc.60.1.82 (Pubitemid 36070868)
29. Modestin, J., Dal Pian, D., &, Agarwalla, P. (2005). Clozapine diminishes suicidal behavior: A retrospective evaluation of clinical records. Journal of Clinical Psychiatry, 66, 534-538. doi: 10.4088/JCP.v66n0418 (Pubitemid 40593584)
30. Moritz, S., Andresen, B., Perro, C., Schickel, M., Krausz, M., &, Naber, D. (2002). Neurocognitive performance in first-episode and chronic schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience, 252, 33-37. (Pubitemid 36056690)
31. Nyakyoma, K., &, Morriss, R. (2010). Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: A 2 year observational study. Psychopharmacology Bulletin, 43, 67-81.
32. Podzebenko, K., Egan, G. F., &, Watson, J. D. (2002). Widespread dorsal stream activation during a parametric mental rotation task, revealed with functional magnetic resonance imaging. Neuroimage, 15, 547-558. doi: 10.1006/nimg.2001.0999 (Pubitemid 34852522)
33. Purdon, S. E., Labelle, A., &, Boulay, L. (2001). Neuropsychological change in schizophrenia after 6 weeks of clozapine. Schizophrenia Research, 48, 57-67. doi: 10.1016/S0920-9964(00)00101-8 (Pubitemid 32241183)
34. Raven, J. C., &, Court, J. H. (1989). Manual for Raven's Progressive Matrices and Vocabulary Scales. Research supplement No. 4: Additional national and American norms, and summaries of normative, reliability, and validity studies. Oxford: Oxford Psychologists Press.
35. Rund, B. R. (2009). Is schizophrenia a neurodegenerative disorder?. Nordic Journal of Psychiatry, 63, 196-201. doi: 10.1080/08039480902767286
36. Seurinck, R., Vingerhoets, G., de Lange, F. P., &, Achten, E. (2004). Does egocentric mental rotation elicit sex differences?. Neuroimage, 23, 1440-1449. doi: 10.1016/j.neuroimage.2004.08.010 (Pubitemid 40260367)
37. Sharma, T., Hughes, C., Soni, W., &, Kumari, V. (2003). Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. Psychopharmacology (Berlin), 169, 398-403. doi: 10.1007/s00213-003-1506-y (Pubitemid 37255529)
38. Shepard, R. N., &, Metzler, J. (1971). Mental rotation of three-dimensional objects. Science, 171, 701-703. doi: 10.1126/science.171.3972. 701
39. Stip, E. (2006). [Cognition, schizophrenia and the effect of antipsychotics]. Encephale, 32, 341-350. doi: 10.1016/S0013-7006(06)76162-0 (Pubitemid 43941530)
40. Tandon, R., Keshavan, M. S., &, Nasrallah, H. A. (2008). Schizophrenia, "just the facts": What we know in 2008. Part 1: Overview. Schizophrenia Research, 100, 4-19. doi: 10.1016/j.schres.2008.01.022
41. Wechsler, D. (1997). Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: Psychological Corporation.
42. Weiss, E., Siedentopf, C. M., Hofer, A., Deisenhammer, E. A., Hoptman, M. J., Kremser, C.,., Delazer, M. (2003). Sex differences in brain activation pattern during a visuospatial cognitive task: A functional magnetic resonance imaging study in healthy volunteers. Neuroscience Letters, 344, 169-172. doi: 10.1016/S0304-3940(03)00406-3 (Pubitemid 36694670)
43. Woodward, N. D., Purdon, S. E., Meltzer, H. Y., &, Zald, D. H. (2005). A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology, 8, 457-472. doi: 10.1017/S146114570500516X (Pubitemid 41002500)